Sugarbaker Paul H
Washington Cancer Institute, 106 Irving Street, NW, Suite 3900, Washington DC,WA 20010, USA.
Int J Surg Oncol. 2011;2011:915078. doi: 10.1155/2011/915078. Epub 2010 Dec 5.
Proper indications for second-look surgery in patients with colorectal cancer have always been a controversial subject. The surgical literature suggests benefit in a reoperation, where a limited extent of cancer is discovered and then resected with negative margins. However, patients are often subjected to a negative exploratory laparotomy or an intervention that is unable to achieve an R-0 resection; in these circumstances, little or no benefit occurs. Unfortunately, an unsuccessful repeat intervention may place the patient in a worse condition, especially if morbidity occurs. This paper seeks to identify the clinical parameters of a primary colorectal cancer and a followup plan that are associated with cancer recurrence that can be definitively addressed by the second look surgery. New surgical technologies, including cytoreductive surgery with peritonectomy and perioperative intraperitoneal chemotherapy with hyperthermia, are suggested for use in this group of patients. This new management strategy used in patients with local-regional recurrence may result in a high proportion of patients converted from a second-look positive patient to a long-term survivor.
结直肠癌患者二次探查手术的恰当指征一直是个有争议的话题。外科文献表明再次手术有好处,即发现癌症范围有限,然后进行切缘阴性的切除。然而,患者常常接受阴性探查性剖腹手术或无法实现R-0切除的干预;在这些情况下,几乎没有益处。不幸的是,一次不成功的重复干预可能会使患者状况更糟,尤其是出现并发症时。本文旨在确定原发性结直肠癌的临床参数以及与癌症复发相关的后续计划,而二次探查手术可以明确解决这些问题。建议对这组患者使用新的手术技术,包括减瘤性腹膜切除术和术中腹腔内热灌注化疗。用于局部区域复发患者的这种新管理策略可能会使很大一部分患者从二次探查阳性患者转变为长期存活者。